Mark D. Plinio

Chief Commercial Officer, Evelo Biosciences, Inc.

Companies

Evelo Biosciences, Inc.Chief Commercial Officer Jun 16, 2021 to Feb 2, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Evelo Biosciences, Inc.3,750 shares²Jan 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 31, 2023Granted 1,250 shares at $0.88 of Evelo Biosciences, Inc.²
Jul 29, 2022Granted 1,250 shares at $1.79 of Evelo Biosciences, Inc.³
Jan 31, 2022Granted 1,250 shares at $4.00 of Evelo Biosciences, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREvelo Biosciences, Inc., Chief Commercial Officer
2
SEC EDGAREvelo Biosciences, Inc. shares after the filing of Jan 31, 2023
3
SEC EDGARForm 4 filed Oct 14, 2022
4
SEC EDGARForm 4 filed Feb 1, 2022